Drew Weissman of the Perelman School of Medicine spoke about adapting COVID-19 vaccines for new variants, which would not require new clinical trials. “We’ve been doing this with flu for many years,” he said. “The variants aren’t that different.”

February 24, 2021 ・ From WBUR Radio (Boston)